Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Ethos | 2026 | Series A | $3.2M | London |
| Latus Bio | 2026 | Series A | Undisclosed | Philadelphia |
| Reserv | 2026 | Series C | $16.0M | New York |
| Saris AI | 2026 | Series A | Undisclosed | San Francisco |
| Cognition | 2026 | Series D | $400.0M | San Francisco |
| ProteinQure | 2026 | Grant | $11.0M | Toronto |
| Armada | 2026 | Series B | $131.0M | San Francisco |
| CREATE Medicines | 2026 | Series B | Undisclosed | Cambridge |
| Fractile | 2026 | Series B | $22.5M | London |
| iCOMAT | 2026 | Grant | $22.5M | Bristol |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Ethos | Series A | $3.2M | London, United Kingdom |
| 2 | Latus Bio | Series A | Undisclosed | Philadelphia, United States |
| 3 | Reserv | Series C | $16.0M | New York, United States |
| 4 | Saris AI | Series A | Undisclosed | San Francisco, United States |
| 5 | Cognition | Series D | $400.0M | San Francisco, United States |
| 6 | ProteinQure | Grant | $11.0M | Toronto, Canada |
| 7 | Armada | Series B | $131.0M | San Francisco, United States |
| 8 | CREATE Medicines | Series B | Undisclosed | Cambridge, United States |
| 9 | Fractile | Series B | $22.5M | London, United Kingdom |
| 10 | iCOMAT | Grant | $22.5M | Bristol, United Kingdom |
Ethos is an AI-driven platform that matches individuals with opportunities.
Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.
Reserv develops an AI-powered insurance claims platform to manage and optimize property and casualty claims.
Saris AI is an artificial intelligence company that builds agent-based workflow automation systems for financial institutions.
Cognition develops artificial intelligence systems for software engineering and code automation.
ProteinQure is a biotech company that designs peptide-based therapeutics and drug delivery systems using AI.
Armada develops computing infrastructure that supports AI processing, connectivity, and data management in remote environments.
CREATE Medicines is a biotech company developing in vivo CAR therapies using mRNA-LNP immune cell programming technology.
Fractile develops semiconductor hardware and AI inference systems for large language model processing.
Revolutionary production equipment for the manufacturing of advanced carbon fibre composite parts.
Valius Sciences offers maximalist oncology diagnostics for personalized cancer treatment.
Chapter offers a Medicare navigation platform that provides advisory services for seniors seeking health coverage.
Sila is a battery materials company that manufactures energy-density lithium-ion batteries for electric vehicles.
Patlytics provides AI-driven patent intelligence solutions to enhance research and efficiency.
Rilian is a cybersecurity innovator that provides an agentic systems integrator for the AI-native security sector.
Addi is a technology company that provides credit and banking solutions.
Hopscotch Primary Care is a healthcare company that aims to transform healthcare for rural communities across the country.
Habi is a digital platform that aims to simplify the process of buying and selling real estate properties.
Loop provides a platform that manages logistics and supply chain data through automation and analytics tools.
Alloy Therapeutics is a biotechnology company that provides drug discovery services to support the development of therapeutic biologics.
KeyCare is a virtual care platform powered by Epic created to support progressive health systems.
Memebox is a consumer company that provides customers with the Asian beauty products, culture, and trends.
Rocketlane is a PSA platform that provides project management and collaboration services.
Automated time, bill review, and firm intelligence for law firms
The Boring Company engages in constructing underground transportation networks.
8VC has invested in 398 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
8VC's top investment sectors include Artificial Intelligence (AI), Information Technology, Biotechnology, Financial Services, Health Care. The firm invests across 68 different industry categories.
Among tracked funding rounds, Cognition received $400.0M in a Series D round. 8VC's total known invested capital is $19.2B.
8VC's average investment size is $64.6M across its portfolio of 398 companies.
Recent 8VC portfolio additions include Ethos, Latus Bio, Reserv, Saris AI, Cognition. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors